Salvador Resino

Head of Laboratory

Instituto de Salud Carlos III

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Salvador Resino is the Head of Laboratory at Instituto de Salud Carlos III in Spain. His research focuses on antiretroviral resistance in HIV, nanotechnology applications in biosensing for viral detection, and the epidemiology of hepatitis C among migrant populations. Additionally, he investigates the long-term effects of COVID-19 on hemostatic and endothelial functions, as well as the immune responses in people living with HIV following vaccination against SARS-CoV-2.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (2)

Rafael Blancas Gómez-Casero

Profesor asociado. Coordinador de Medicina Legal y Toxicología. Profesor de Patología Crítica

Universidad Alfonso X el Sabio

SPAIN

View details

OLGA CANO MORATO

Instituto de Salud Carlos III

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Salvador Resino

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Long-Term Hemostatic and Endothelial Dysregulation Associated with Cardiovascular Events in Survivors of COVID-19 Previously Admitted to the ICU

Machine‐learning analysis identifies “elite” viral controllers with increased survival and homeostatic responses in critical COVID‐19

Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers.

Advances in Nanotechnology‐Enabled Optical Biosensors for Dengue Virus Detection: A Systematic Review

Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023

From Management to Cure: The Shifting Paradigm in HIV and Chronic Viral Hepatitis

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis

Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination

Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and non-septic shock patients.

Dynamics of coagulation proteins upon ICU admission and after one year of recovery from COVID-19: a preliminary study

Collaborators (2)

Rafael Blancas Gómez-Casero

OLGA CANO MORATO

Make your next move.